@169
>MenQuadfi has a 5.3 % rate of infants suffering serious adverse reactions while Menveo showed an injury/adverse reaction rate of 3.5%.
bad bad bad
tyb!
@169
>MenQuadfi has a 5.3 % rate of infants suffering serious adverse reactions while Menveo showed an injury/adverse reaction rate of 3.5%.
bad bad bad
tyb!